Comparative behavioural profile of centrally administered tachykinin NK1, NK2 and NK3 receptor agonists in the guinea-pig.

Por Piot, O., Betschart, J., Grall, I., Ravard, S., Garret, C., Blanchard, J. C.
Publicado em 1995

A non-peptide NK1-receptor antagonist, RP 67580, inhibits neurogenic inflammation postsynaptically.

Por Moussaoui, S. M., Montier, F., Carruette, A., Blanchard, J. C., Laduron, P. M., Garret, C.
Publicado em 1993

Pharmacological properties of a potent and selective nonpeptide substance P antagonist.

Por Garret, C, Carruette, A, Fardin, V, Moussaoui, S, Peyronel, J F, Blanchard, J C, Laduron, P M
Publicado em 1991

Cyclic cholecystokinin analogues with high selectivity for central receptors.

Por Charpentier, B, Pelaprat, D, Durieux, C, Dor, A, Reibaud, M, Blanchard, J C, Roques, B P
Publicado em 1988

Altered synaptic plasticity and memory formation in nitric oxide synthase inhibitor-treated rats.

Por Böhme, G A, Bon, C, Lemaire, M, Reibaud, M, Piot, O, Stutzmann, J M, Doble, A, Blanchard, J C
Publicado em 1993

Pharmacological characterization of RP 62203, a novel 5-hydroxytryptamine 5-HT(2) receptor antagonist

Por Doble, A., Girdlestone, D., Piot, O., Allam, D., Betschart, J., Boireau, A., Dupuy, A., Guérémy, C., Ménager, J., Zundel, J.L., Blanchard, J.C.
Publicado em 1992